News > Covaxin: The Phase 3 Efficacy Data Is Still Missing - but Who Cares?

Covaxin: The Phase 3 Efficacy Data Is Still Missing - but Who Cares?

Even as phase 3 efficacy data remains wanting for Bharat Biotech’s COVID-19 vaccine candidate, the Government of India has announced plans to purchase 5.5 million doses to be delivered to 12 centres around the country by January 14, to be administered in the vaccination drive’s first phase. Each dose is expected to be priced Rs 295, bringing the purchase cost to Rs 162.25 crore.

Prime Minister Narendra Modi had said yesterday the government will draw from the controversial PM CARES fund to foot these bills.